A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies

CP Lee; Maja de Jonge; AE O'Donnell; KL Schothorst; J Hanwell; JB Chick; Rik Brooimans; LM Adams; DW Drolet; JS de Bono; SB Kaye; IR Judson; Jaap Verweij

doi:10.1158/1078-0432.CCR-05-1932

A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies

CP Lee, Maja de Jonge, AE O'Donnell, KL Schothorst, J Hanwell, JB Chick, Rik Brooimans, LM Adams, DW Drolet, JS de Bono, SB Kaye, IR Judson, Jaap Verweij

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2841-2848
Number of pages	8
Journal	Clinical Cancer Research
Volume	12
Issue number	9
DOIs	https://doi.org/10.1158/1078-0432.CCR-05-1932
Publication status	Published - 2006

Access to Document

10.1158/1078-0432.CCR-05-1932

http://hdl.handle.net/1765/21768

Cite this

Lee, CP., de Jonge, M., O'Donnell, AE., Schothorst, KL., Hanwell, J., Chick, JB., Brooimans, R., Adams, LM., Drolet, DW., de Bono, JS., Kaye, SB., Judson, IR., & Verweij, J. (2006). A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies. Clinical Cancer Research, 12(9), 2841-2848. https://doi.org/10.1158/1078-0432.CCR-05-1932

@article{cce912dd8b4a4b8db90ea7eb92bad3e5,

title = "A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies",

author = "CP Lee and {de Jonge}, Maja and AE O'Donnell and KL Schothorst and J Hanwell and JB Chick and Rik Brooimans and LM Adams and DW Drolet and {de Bono}, JS and SB Kaye and IR Judson and Jaap Verweij",

year = "2006",

doi = "10.1158/1078-0432.CCR-05-1932",

language = "Undefined/Unknown",

volume = "12",

pages = "2841--2848",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "9",

}

Lee, CP, de Jonge, M, O'Donnell, AE, Schothorst, KL, Hanwell, J, Chick, JB, Brooimans, R, Adams, LM, Drolet, DW, de Bono, JS, Kaye, SB, Judson, IR & Verweij, J 2006, 'A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies', Clinical Cancer Research, vol. 12, no. 9, pp. 2841-2848. https://doi.org/10.1158/1078-0432.CCR-05-1932

TY - JOUR

T1 - A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies

AU - Lee, CP

AU - de Jonge, Maja

AU - O'Donnell, AE

AU - Schothorst, KL

AU - Hanwell, J

AU - Chick, JB

AU - Brooimans, Rik

AU - Adams, LM

AU - Drolet, DW

AU - de Bono, JS

AU - Kaye, SB

AU - Judson, IR

AU - Verweij, Jaap

PY - 2006

Y1 - 2006

U2 - 10.1158/1078-0432.CCR-05-1932

DO - 10.1158/1078-0432.CCR-05-1932

M3 - Article

VL - 12

SP - 2841

EP - 2848

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 9

ER -